Cybin Archives

Psychedelics News

Cybin

Don’t Miss

20 Jun 2022

News You Might Have Missed: June 20th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Finance

14 Jun 2022

Canaccord Gives Cybin 10x Price Target

We have another major analyst, Canaccord Genuity, coming out with strong buy ratings for Cybin....

By Jason Najum

Culture

10 Jun 2022

Elon Musk Tweets Psychedelics With Cybin CEO

Elon Musk has made waves again, talking about potential of psychedelics...

By Microdose NewsDesk

Finance

9 Jun 2022

Roth Capital Doubles Down on Cybin After DMT Acquisition

Roth Capital has reiterated its Buy rating and bullish price target for Cybin, a sign of faith in the company's programs considering the difficult market conditions....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Don’t Miss

6 Jun 2022

News You Might Have Missed: June 6th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Industry

31 May 2022

Cybin Submits IND to FDA for Phase 1/2a Trial of CYB003

Cybin moved their pipeline forward, submitting an IND to the FDA for a Phase 1/2a clinical trial for CYB-003...

By Jason Najum

Industry

21 Apr 2022

Cybin Announces Partnership for CYB-003 Trial

Cybin has announced a partnership with a leading CRO (Clinilabs) to help them with their upcoming trial for lead candidate compound CYB-003...

By Jason Najum

Industry

13 Apr 2022

Cybin Announces Positive Data on CYB004 DMT

Delivery of CYB004 via inhalation showed significant advantages over intravenously administered dimethyltryptamine (“IV DMT”) in preclinical studies...

By Microdose

Industry

29 Mar 2022

Cybin Announces Successful Completion of CYB003 Preclinical Studies

Today we got some follow-up news on Cybin'sB-003 program, with positive pre-clinical results that will hopefully pave the way for their upcoming human trials....

By Jason Najum

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result